Filter
848
Text search:
infectious
substances
Featured
Recommendations
112
New Publications
186
Language
Document type
No document type
385
Guidelines
207
Studies & Reports
104
Manuals
75
Strategic & Response Plan
36
Training Material
22
Situation Updates
7
Fact sheets
6
Resource Platforms
2
Infographics
2
Brochures
1
Countries / Regions
India
37
South Africa
36
Kenya
32
Global
28
Western and Central Europe
25
Nigeria
20
Ghana
19
Ethiopia
15
Sierra Leone
14
Zambia
14
Uganda
13
Liberia
11
Tanzania
11
Namibia
9
Eswatini/ Swaziland
9
Bangladesh
8
Myanmar / Burma
8
Africa
7
Philippines
6
Nepal
6
Rwanda
6
Botswana
6
Eastern Europe
6
Guinea
5
Syria
5
Ukraine
5
Latin America and the Carribbean
5
Zimbabwe
4
Germany
4
Mozambique
4
Angola
4
Eastern Europe and Central Asia
4
Congo, Democratic Republic of
3
Cameroon
3
Indonesia
3
Brazil
3
North Macedonia
3
Lesotho
3
West and Central Africa
3
South–East Asia Region
3
Russia
3
Guinea-Bissau
2
Togo
2
South Sudan
2
Malawi
2
Yemen
2
Middle East and North Africa
2
Western Pacific Region
2
Poland
2
Tajikistan
2
Georgia
2
United Kingdom
2
Burkina Faso
1
Senegal
1
Mali
1
Côte d’Ivoire / Ivory Coast
1
USA
1
Haiti
1
Pakistan
1
Iraq
1
Jordan
1
Afghanistan
1
Chad
1
Cambodia
1
Thailand
1
Singapore
1
Papua New Guinea
1
Sudan
1
Argentina
1
Peru
1
Switzerland
1
Serbia
1
Hungary
1
Sri Lanka
1
East and Southern Africa
1
Asia
1
Albania
1
Southern Africa
1
Estonia
1
Romania
1
Moldova
1
Iran
1
Uzbekistan
1
Kyrgyzstan
1
France
1
Maldives
1
Mauritius
1
Latvia
1
Authors & Publishers
Publication Years
Category
Countries
276
Clinical Guidelines
60
Key Resources
46
Pharmacy & Technologies
37
Public Health
36
Women & Child Health
22
Capacity Building
17
Toolboxes
AMR
73
COVID-19
73
Mental Health
68
HIV
56
TB
50
Rapid Response
47
Pharmacy
47
Planetary Health
42
Ebola & Marburg
33
Caregiver
27
2.0 Rapid Response
21
NTDs
16
NCDs
15
Malaria
15
Specific Hazards
13
Conflict
10
Global Health Education
10
Zika
9
Natural Hazards
8
Refugee
4
Disability
3
Cholera
3
Polio
2
Health Financing Toolbox
2
The purpose of this document is to provide interim guidance to laboratories and stakeholders involved in laboratory testing of patients who meet the definition of suspected case of pneumonia associated with a novel coronavirus identified in Wuhan, China.
19 March 2020
This update of the Guidelines for poison control, entitled Guidelines for establishing a poison centre, reflects the development of the role of poison centres in public health and the sound management of chemicals, described in section 1, and the opportunities provided by new technology. Assessments
...
World Drug Report 2017
-1-
Accessed: 14.03.2019
The harmful use of alcohol causes approximately 3 million deaths every year and the overall burden of disease and injuries attributable to alcohol consumption remains unacceptably high. The pace of development and implementation of alcohol policies has been uneven in WHO regions, and resources and c
...
Laboratory Biossafety Manual
Caring for burns patients from the incident scene to definitive treatment can be a complex, resource-consuming process with the potential to overwhelm health system capacity.This document provides practical guidance for building capacity and capability for burns care from clinical, human resources a
...
Report by the Director-General. 75th World health assembly 25 April 2022
Policy Brief | April 2015 | This brief accompanies the data sheet, Addressing Risk Factors for Noncommunicable Diseases Among Young People in Africa: Key to Prevention and Sustainable Development, and its data appendix, which provide all available country-specific data on four key NCD risk factors a
...
Polymerase Chain Reaction (PCR) has significantly helped in early diagnosis and commencement of specific interventions for diseases control. It also plays a critical role in understanding the disease epidemiology and unraveling the transmission dynamics of the disease. This manual intends to p
...
Report of the 23rd WHO Expert Committee on the selection and use of essential medicines
This executive summary reports the recommendations made by the Expert Committee for the 2021 update of the WHO Model List of Essential Medicines (EML) and the Model List of Essential Medicine for Children (EMLc)
...
Examination of the business behavior of Boehringer Ingelheim, Bayer and Baxter in India